Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can feedback and legal reminders stop pharmacies from giving antibiotics without a prescription?

NCT ID NCT07284914

Knowledge-focused Sponsor: Penn State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study tests two simple interventions for community pharmacies in Ghana: giving them personalized feedback on their antibiotic dispensing habits, and sending a legal reminder that dispensing antibiotics without a prescription is against the law. Researchers will measure whether these approaches lower the rate of non-prescription antibiotic sales. The goal is to gather evidence to help design future policies that fight antimicrobial resistance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide evidence for policies that reduce unnecessary antibiotic use, helping to slow antimicrobial resistance in communities.
What could go wrong
This is an early-stage behavioral study with 285 pharmacies, not a clinical treatment trial. Results may not generalize to other regions or lead to lasting change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 285 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for community pharmacies: * Operating within the Greater Accra region of Ghana * Registered with Ghana Pharmacy Council * "Stand-alone", i.e., not affiliated or next to a hospital Exclusion Criteria: * Operating only outside the Greater Accra region of Ghana * Not registered with Ghana Pharmacy Council * Hospital pharmacy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Upper resp tract infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Upper resp tract infection

Contacts and locations

Locations

  • University of Ghana, Regional Institute for Population Studies

    Legon, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.